Scroll to top

2016 Announcements

CLINUVEL
Posted by CLINUVEL
January 31, 2017

Appendix 4C - Quarterly report

31 January 2017 Enclosed is the quarterly report for the period ending...

Read More
CLINUVEL
Posted by CLINUVEL
December 22, 2016

Appendix 3Y

22 December 2016 We (the entity) give ASX the following information under...

Read More
CLINUVEL
Posted by CLINUVEL
December 20, 2016

CLINUVEL Newsletter - December 2016

20 December 2016 At the end of a calendar year we look...

Read More
CLINUVEL
Posted by CLINUVEL
December 12, 2016

Appendix 3Y

12 December 2016 We (the entity) give ASX the following information under...

Read More
CLINUVEL
Posted by CLINUVEL
November 28, 2016

Results of Meeting

28 November 2016 In accordance with Listing Rule 3.13.2 and section 251AA...

Read More
CLINUVEL
Posted by CLINUVEL
November 27, 2016

Chair's Address to the Annual General Meeting

27 November 2017 I would like to commence my address by saying...

Read More
CLINUVEL
Posted by CLINUVEL
November 27, 2016

Managing Director's AGM Presentation

27 November 2016 Good morning and welcome to CLINUVEL’s Annual General Meeting....

Read More
CLINUVEL
Posted by CLINUVEL
November 8, 2016

CLINUVEL agrees with FDA on New Drug Application timelines

8 November 2016  CLINUVEL today announced that it met on 7 November with...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2016

Response to Price Query

31 October 2016 Enclosed is CLINUVEL PHARMACEUTICALS LTD’s response to a price...

Read More
CLINUVEL
Posted by CLINUVEL
October 31, 2016

Appendix 4C

31 October 2016 Enclosed is the quarterly report for the period ending...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2016

Notice of Annual General Meeting/Proxy Form

26 October 2016 This Explanatory Memorandum has been prepared for the Shareholders...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2016

Appendix 4G

26 October 2016 Enclosed is the Corporate Governance Council Principles and Recommendations...

Read More
CLINUVEL
Posted by CLINUVEL
October 22, 2016

CLINUVEL relocates Melbourne office

24 October 2016 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...

Read More
CLINUVEL
Posted by CLINUVEL
October 22, 2016

FDA erythropoietic protoporphyria (EPP) scientific workshop

24 October 2016 The US Food and Drug Administration (FDA) will today...

Read More
CLINUVEL
Posted by CLINUVEL
October 16, 2016

SCENESSE® NICE ENGLAND UPDATE

18 October 2016  CLINUVEL [ASX: CUV; Nasdaq International Designation ADR: CLVLY; Xetra-DAX: UR9] today...

Read More
We use cookies to give you the best experience.